Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Director departure
Inv. presentation
|
|
Targeted Medical Pharma, Inc. (TRGM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/17/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/22/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 10/18/2018 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 12/12/2017 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 04/14/2016 |
10-K
| Annual Report for the period ended December 31, 2015 |
| 03/31/2016 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
| 03/08/2016 |
4
| Wenkart Thomas Richard (10% Owner) has filed a Form 4 on Targeted Medical Pharma, Inc. |
| 03/07/2016 |
4
| Weems Kerry Neil (Director) has filed a Form 4 on Targeted Medical Pharma, Inc.|
Txns:
| Granted 200,000 shares
@ $0.05, valued at
$10k
Granted 100,000 options to buy
@ $0.05, valued at
$5k
|
|
| 03/07/2016 |
4
| Silver David Samuel (Chief Medical Officer) has filed a Form 4 on Targeted Medical Pharma, Inc.|
Txns:
| Granted 575,000 shares
@ $0.05, valued at
$28.8k
Disposed of 177,469 options to buy
@ $3.38, valued at
$599.8k
Disposed of 400,000 options to buy
@ $3.38, valued at
$1.4M
Granted 400,000 options to buy
@ $0.05, valued at
$20k
|
|
| 03/07/2016 |
4
| Giffoni Kim (CEO) has filed a Form 4 on Targeted Medical Pharma, Inc.|
Txns:
| Granted 547,500 shares
@ $0.05, valued at
$27.4k
Granted 300,000 options to buy
@ $0.05, valued at
$15k
|
|
| 03/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/07/2016 |
4
| Horne William B (CFO) has filed a Form 4 on Targeted Medical Pharma, Inc. |
| 02/16/2016 |
SC 13G/A
| DERMA MEDICAL SYSTEMS INC. has filed a Schedule 13D for TARGETED MEDICAL PHARMA, INC. |
| 02/04/2016 |
4
| Wenkart Thomas Richard (10% Owner) has filed a Form 4 on Targeted Medical Pharma, Inc. |
| 11/13/2015 |
10-Q
| Quarterly Report for the period ended September 30, 2015 |
| 10/01/2015 |
8-K
| Quarterly results |
| 08/13/2015 |
10-Q
| Quarterly Report for the period ended June 30, 2015 |
| 05/15/2015 |
10-Q
| Quarterly Report for the period ended March 31, 2015 |
| 04/14/2015 |
10-K
| Annual Report for the period ended December 31, 2014 |
| 03/03/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/27/2015 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 02/11/2015 |
SC 13G/A
| DERMA MEDICAL SYSTEMS INC. reports a 17.2% stake in TARGETED MEDICAL PHARMA, INC. |
| 02/06/2015 |
8-K
| Resignation/termination of a director |
| 01/20/2015 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits |
| 01/12/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/07/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/06/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/14/2014 |
10-Q
| Quarterly Report for the period ended September 30, 2014 |
| 08/14/2014 |
10-Q
| Quarterly Report for the period ended June 30, 2014 |
| 06/11/2014 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 05/20/2014 |
10-Q
| Quarterly Report for the period ended March 31, 2014 |
| 05/20/2014 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 04/30/2014 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/09/2014 |
SC 13G
| DERMA MEDICAL SYSTEMS INC. reports a 9.2% stake in TARGETED MEDICAL PHARMA, INC. |
|
|
|